org placeholder image

Steve Oloughlin

Chief Financial Officer at Actinium Pharmaceuticals

  • LinkedIn
map
ACTINIUM PHARMACEUTICALS

ACTINIUM PHARMACEUTICALS

  • description Description
    Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #B...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 50 Million to 100 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Actinium Pharmaceuticals Org Chart and Mapping

Employees

Mary Chen

Vice President of Clinical Development

Jason Scott

Medical Sales Representative

Gajanan Dewkar

Associate Director, Radiopharmaceutical Product Development

Jason Li

Senior Research Associate

Yuting Chou

Clinical Trial Associate

Betsy King

Director, Quality and Regulatory Affairs

Frequently Asked Questions Regarding Steve Oloughlin

Answer: Steve Oloughlin works for Actinium Pharmaceuticals as Chief Financial Officer

Answer: Steve Oloughlin’s role in Actinium Pharmaceuticals is Chief Financial Officer

Answer: Steve Oloughlin's email address is s***@gmail.com

Answer: Steve Oloughlin's business email address is s****@actiniumpharmaceuticals.com

Answer: Steve Oloughlin’s direct phone number is (***)-***-****

Answer: Steve Oloughlin works in the industry of: Biotechnology

Answer: Steve Oloughlin works Actinium Pharmaceuticals located at 275 Madison Ave, New York, 10016, United States

Answer: Actinium Pharmaceuticals's Chief Financial Officer is Steve Oloughlin

Answer: Steve Oloughlin contact details:

  • Phone number  :  (***)-***-****
  • Email  :  s****@actiniumpharmaceuticals.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access